"Fundada l'any 1900, MútuaTerrassa és una entitat de benefici social que té per missió el servei a les persones, anticipant i resolent situacions i problemes relacionats amb la salut, l'autonomia personal o el seu benestar. Actua en l'àmbit geogràfic fonamentalment de Catalunya i en algunes activitats a tot el territori espanyol."

During the past decade, Hospital Mutua De Terrasa; Servicio de Neurologia conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Mutua De Terrasa; Servicio de Neurologia" are "Alzheimer's Disease" (4 trials) and "Alzheimer Disease" (3 trials). Many other conditions were trialed in "Hospital Mutua De Terrasa; Servicio de Neurologia" in a lesser frequency.

Most popular intervention types in "Hospital Mutua De Terrasa; Servicio de Neurologia" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Gantenerumab" (4 trials), "Placebo" (4 trials) and "Crenezumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Mutua De Terrasa; Servicio de Neurologia" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Mutua De Terrasa; Servicio de Neurologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital Mutua De Terrasa; Servicio de Neurologia, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Mutua De Terrasa; Servicio de Neurologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".